Answers are grounded in this paper and cite their sources.
is a strategy for mitigating c9ALS/FTD-associated pathologies and studying disease-associated pathways in preclinical models.
No takes yet. Share an insight, caveat, or question.
Bush et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: